<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
	<channel>
		<title>Canadian PKU and Allied Disorders - Articles</title>
		<link>http://www.canpcu.org/</link>
		<description>Articles from Canadian PKU and Allied Disorders</description>
		<pubDate>Fri, 09 Jan 2026 00:00:00 +0000</pubDate>
		<language>en</language> 
		<item>
			<title>Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases</title>
			<link>http://www.canpcu.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=19</link>
			<pubDate>Fri, 09 Jan 2026 00:00:00 +0000</pubDate>
			<category>PKU/PCU - Phenylketonuria/Ph&#xe9;nylc&#xe9;tonurie</category> 
			<guid isPermaLink="false">http://www.canpcu.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=19</guid>
			<description>This article is presented in English. The article comes from Aurora Therapeutics.
Cet article est presente en anglais. L&apos;article provient d&apos;Aurora Therapeutics.</description>
		</item>
		
		<item>
			<title>Sephience, nouveau traitement pour la ph&#xe9;nylc&#xe9;tonurie, est approuv&#xe9; au Canada :</title>
			<link>http://www.canpcu.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=18</link>
			<pubDate>Sat, 08 Nov 2025 00:00:00 +0000</pubDate>
			<category>PKU/PCU - Phenylketonuria/Ph&#xe9;nylc&#xe9;tonurie</category> 
			<guid isPermaLink="false">http://www.canpcu.org/index.cfm?fuseaction=Feature.showFeature&amp;featureID=18</guid>
			<description>Cet article est presente en francais. L&apos;article provient de Carnet Ph&#xe9;nylc&#xe9;tonurie par Tristan.
This article is presented in French. The article comes from Carnet Ph&#xe9;nylc&#xe9;tonurie by Tristan.

</description>
		</item>
		
	</channel>
</rss> 